Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2012 Feb 10;18(8):1281–1286. doi: 10.1016/j.bbmt.2012.02.001

Figure 1.

Figure 1

A) Severe keratinocyte dysplasia (SKD) and GVHD in a patient 35 days post-transplant. The skin exhibits enlarged cells, enlarged nuclei, irregular nuclear contours, and prominent nucleoli. Keratohyaline granules are prominent. A fragmenting nucleus may be seen in the mid epidermis on the left. This skin additionally shows evidence of GVHD, with a lymphocyte (large arrow) and apoptotic cell (small arrow), and abundant lymphocytes in the dermis. B) SKD in a patient 77 days post-transplant. There is epidermal atrophy, along with the features of SKD of enlarged cells, enlarged nuclei, and prominent nucleoli.